Urogen's Chief Medical Officer Insider Trade: 400K Sale Insights
A high-profile insider sale at UroGen Pharma raises questions about market signals and biotech risk. This article unp...
A yearly strategy formalizes harvest windows, helping you optimize tax outcomes while staying invested in index funds.
22,166 articlesA high-profile insider sale at UroGen Pharma raises questions about market signals and biotech risk. This article unp...
A growing glut inventory way—how should savvy investors respond when supply rises and loan terms shift? This guide br...
A sudden, sizable stake in Resideo Technologies has sent its stock climbing 66%. Alta Fox Capital Management disclose...
The bitcoin treasury strategy that propelled MicroStrategy into crypto prominence is under stress as bitcoin prices r...
Private SpaceX uses extended lockups for insiders, signaling a disciplined cash strategy. This article breaks down wh...
Cracking the code on a potential real estate rebound? play means stacking three strategic bets: affordable debt, grow...
What to watch in jfrog (frog) 2026 earnings: ARR trends, cloud mix, and expansion strategy. This guide translates the...
When a top executive sells shares, investors tune in. This article breaks down what a recent move by Ladder Capital's...
A new player in the chip foundry race is signaling aggressive pricing. If a potential rival wants undercut, investors...
Saylor’s Strategy rolls out a Digital Credit Capital Framework to bolster BTC exposure and liquidity, aiming to calm ...
A midrange, budget-friendly Apple device could broaden the company’s market and boost services revenue. This guide an...
VFVA has posted solid gains by targeting cheap U.S. equities, but a hidden volatility risk lies in its deep value app...